iodixanol has been researched along with Chronic Disease in 11 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combined prophylactic strategy of sodium bicarbonate plus N-acetylsyteine (NAC) seems to be effective in preventing contrast induced acute kidney injury (CI-AKI) in patients at low-to-medium risk." | 6.25 | Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. ( Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Zhao, HW | 1 |
| Zhang, XJ | 1 |
| Chen, BJ | 1 |
| Yu, GN | 1 |
| Hou, AJ | 1 |
| Luan, B | 1 |
| Stojanovska, J | 1 |
| Cronin, P | 1 |
| Gross, BH | 1 |
| Kazerooni, EA | 1 |
| Tsodikov, A | 1 |
| Frank, L | 1 |
| Oral, H | 1 |
| Solomon, R | 1 |
| Matejka, J | 1 |
| Varvarovsky, I | 1 |
| Vojtisek, P | 1 |
| Herman, A | 1 |
| Rozsival, V | 1 |
| Borkova, V | 1 |
| Kvasnicka, J | 1 |
| Hu, S | 1 |
| Akhlaghi, F | 1 |
| Chitnis, S | 1 |
| Chiu, R | 1 |
| Go, S | 1 |
| Rout, P | 1 |
| Steffes, M | 1 |
| Abbott, JD | 1 |
| Dworkin, L | 1 |
| Bostom, A | 1 |
| Briguori, C | 1 |
| Visconti, G | 1 |
| Ricciardelli, B | 1 |
| Condorelli, G | 1 |
| Lardo, AC | 1 |
| Cordeiro, MA | 1 |
| Silva, C | 1 |
| Amado, LC | 1 |
| George, RT | 1 |
| Saliaris, AP | 1 |
| Schuleri, KH | 1 |
| Fernandes, VR | 1 |
| Zviman, M | 1 |
| Nazarian, S | 1 |
| Halperin, HR | 1 |
| Wu, KC | 1 |
| Hare, JM | 1 |
| Lima, JA | 1 |
| Deray, G | 1 |
| Barrett, BJ | 1 |
| Katzberg, RW | 1 |
| Thomsen, HS | 1 |
| Chen, N | 1 |
| Sahani, D | 1 |
| Soulez, G | 1 |
| Heiken, JP | 1 |
| Lepanto, L | 1 |
| Ni, ZH | 2 |
| Nelson, R | 1 |
| Solomon, RJ | 1 |
| Natarajan, MK | 1 |
| Doucet, S | 1 |
| Sharma, SK | 1 |
| Staniloae, CS | 1 |
| Katholi, RE | 1 |
| Gelormini, JL | 1 |
| Labinaz, M | 1 |
| Moreyra, AE | 1 |
| Reed, PS | 1 |
| Dixon, SR | 1 |
| Boura, JA | 1 |
| O'Neill, WW | 1 |
| Kahn, JK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Microvascular Obstruction by Contrast-enhanced MRI Following Percutaneous Coronary Interventions[NCT00692991] | 144 participants (Actual) | Observational | 1999-10-31 | Completed | |||
| Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging[NCT00857792] | 120 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease[NCT00498342] | 0 participants | Interventional | 2007-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
(NCT00857792)
Timeframe: 3 months
| Intervention | % accurately detected perfusion defects (Number) |
|---|---|
| Open Label | 78 |
1 review available for iodixanol and Chronic Disease
| Article | Year |
|---|---|
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
4 trials available for iodixanol and Chronic Disease
| Article | Year |
|---|---|
Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarker | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Double-Blind Method; Female; Humans; Iopamidol; Kidney | 2006 |
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Cardiac Catheterization; Chronic Disease; Contrast Media; Creatinine; Doubl | 2007 |
7 other studies available for iodixanol and Chronic Disease
| Article | Year |
|---|---|
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Topics: Aged; Biomarkers; Blood Pressure; China; Chronic Disease; Contrast Media; Coronary Angiography; Coro | 2019 |
Left atrial function and maximum volume as determined by MDCT are independently associated with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Function, Left; Chronic Disease; Cohort Studies; Contrast M | 2014 |
Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Topics: Chronic Disease; Contrast Media; Coronary Angiography; Diabetic Nephropathies; Humans; Inpatients; I | 2010 |
Comparison of plasma clearance of iodixanol during versus after angiography.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Coronary Angiography; Female; Glomerular Filtration Ra | 2010 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Iodixanol and chronic kidney disease.
Topics: Chronic Disease; Contrast Media; Diabetic Nephropathies; Humans; Kidney Diseases; Triiodobenzoic Aci | 2006 |
Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Topics: Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Coronary Angiography; Female; Gadolinium D | 2007 |